MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $37,000 | +146.7% | 2,000 | -80.0% | 0.00% | +300.0% |
| Q3 2018 | $15,000 | -25.0% | 10,000 | -54.1% | 0.00% | -50.0% |
| Q1 2018 | $20,000 | -62.3% | 21,800 | +77.2% | 0.00% | 0.0% |
| Q4 2017 | $53,000 | -25.4% | 12,300 | +55.9% | 0.00% | -33.3% |
| Q3 2017 | $71,000 | -81.5% | 7,891 | -86.5% | 0.00% | -80.0% |
| Q2 2017 | $383,000 | +3730.0% | 58,405 | +6100.1% | 0.02% | – |
| Q1 2017 | $10,000 | -68.8% | 942 | -81.7% | 0.00% | -100.0% |
| Q4 2016 | $32,000 | -88.1% | 5,142 | -75.1% | 0.00% | -91.7% |
| Q3 2016 | $269,000 | +934.6% | 20,622 | +76.3% | 0.01% | +1100.0% |
| Q2 2016 | $26,000 | +1200.0% | 11,700 | +154.3% | 0.00% | – |
| Q1 2016 | $2,000 | -94.4% | 4,600 | -34.4% | 0.00% | -100.0% |
| Q4 2015 | $36,000 | – | 7,010 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |